With a staggering 28.4 million new cancer cases projected by 2024, the urgency for improved treatments has never been greater.
While the rapid advancement of personalized treatments has transformed oncology, it has brought with it a host of new considerations, complexities, and challenges that sponsors must overcome.
This free ebook shines a light on how adopting agile, flexible solutions such as adaptive trial designs and customizable assays can support oncology trials
Insights into the importance of customization: Gain a deep understanding of essential tailor-made laboratory services required for achieving clinical trial endpoints.
An agile approach for oncology trials: Learn about oncology trial best practices in laboratory services and why it is important to build in flexibility.
Leveraging laboratory services providers’ capabilities: Discover how you can effectively bring together outsourced laboratory services to advance oncology trials, including customized assays, a global laboratory network and more.
Our specialty laboratory solutions can fit into your current clinical development plans. Even if you are using another central laboratory provider, our agile approach and customer-centric view allows you to communicate scientist to scientist easily
Since 1992, Cerba Research has pioneered the art of human genetic testing. Thanks to this experience, we are able to collaborate with the life science community to provide the most suitable genomic service and enhance the power of your genetic material.
With 25 years of extensive expertise in providing flow cytometry testing for clinical trials ranging from phase I to phase III, Cerba Research has a strong track record of developing and validating custom-made flow cytometry panels.
Developing Cell and Gene Therapies requires an increased need to access expertise, knowledge, data and insights to bring the right patient to the right treatment at the right time.
Reach out to our experts and discover how we can help you transform your research and advance your clinical trials.
